Concretely: constipation · eight · orforglipron. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every…
titration
Page 5 of 19 · 444 questions tagged titration.
What I am working with: 20 mg · eight weeks · constipation. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
I am asking about the protocol logic rather than about my own case specifically. This is presented as though it settles something, and I am not convinced it does. I…
What I have: SUSTAIN-6 · early satiety · 50 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Details up front: SURMOUNT-OSA · hair thinning · 4 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
The particulars: reflux · ecnoglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
My records go back to the first dose with dates, so I can reconstruct the timeline exactly. I would like to know the limits of what can be inferred from this. What I…
Numbers first: dizziness · five · liraglutide. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.…
Numbers first: STEP 2 · 2.5 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…
This matters because it predicts what a related molecule should do. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked…
What I am working with: 20 mg · two weeks · constipation. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.…
Concretely: REDEFINE-1 · vomiting · 5 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The label documentation for the agent in question is ambiguous on exactly this point. The figures are clear enough; the question is what they mean and what they do…
Conditions: SURMOUNT-4 · 30 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
The case in front of me: PIONEER-4 · 2 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
This came up because two published schedules for the same agent differ. I would like help reading this properly rather than being told what conclusion to reach. I…
Details up front: 30 mg · sixteen weeks · reflux. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
What I have: 8 mg · sixteen weeks · reflux. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
The specifics, since they change the answer: FLOW · 60 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Concretely: 2.5 mg · four weeks · hair thinning. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
Setup, so nobody has to ask: PIONEER-1 · fatigue · 10 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
The label documentation for the agent in question is ambiguous on exactly this point. I have read the primary source rather than the summary, which has left me with…
Setup, so nobody has to ask: SUSTAIN-6 · 50 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
What I have: injection-site erythema · five · oral semaglutide. I would like to understand the steps well enough to explain them to someone else. I have access to a…